Passage Bio (PASG) Financials

$4.77

$-0.09 (-1.85%)

As on 15-Sep-2026 16:00EDT

Market cap

$16 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

3.5

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	0.31	0.73	3.08	3.72	3.68	1.54
Gross Profit	-0.31	-0.73	-3.08	-3.72	-3.68	-1.54
Operating Expenses	39.53	42.42	70.40	96.42	138.39	185.73
Operating Profit (EBIT)	-39.66	-43.15	-70.40	-100.14	-138.39	-185.73
Other Income	--	--	--	--	1.72	-0.06
Profit before Tax	-36.11	-45.52	-64.77	-102.06	-136.13	-185.39
Provision for Tax	--	--	0.00	5.39	0.73	6.11
Profit after Tax (Net Income)	-36.11	-45.52	-64.77	-102.06	-136.13	-185.39
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-136.13	-185.39

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	4.46	18.76	61.26	111.28	201.37	318.66
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	20.44	21.79	22.92	23.83	6.92
Current Liabilities	20.72	23.08	19.36	16.34	18.35	29.50
Total Liabilities	45.89	62.28	102.41	150.55	243.55	355.08

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	--	14.52	23.60	32.59	46.51	30.01
Current Assets	25.18	47.76	78.82	117.96	197.04	325.07
Total Assets	45.89	62.28	102.41	150.55	243.55	355.08
Total Debt*	--	24.01	25.48	26.29	27.11	--
Net Current Assets	4.46	24.68	59.45	101.62	178.69	295.57

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-31.51	-47.96	-78.26	-118.21	-126.88
Cash Flow from Investing Activities	--	40.22	54.95	65.24	25.20	-45.81
Cash from Financing Activities	--	0.02	8.87	0.14	-1.35	166.66
Net Cash Inflow / Outflow	--	--	--	--	-94.36	-6.04

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-11.33	-14.35	-20.87	-37.15	-49.85	-68.67
Cash EPS ($)	--	-14.12	-19.88	-35.75	-48.50	-68.10
Adjusted Book Value ($)	--	5.91	19.74	40.51	73.74	118.03
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-9.93	-15.45	-28.49	-43.29	-47.00
Free Cash Flow per Share ($)	--	-9.93	-15.47	-28.54	-45.22	-56.49

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-70.30	-57.75	-55.76	-49.76	-59.48
ROE (%)	-311.16	-113.78	-75.07	-65.29	-52.35	-59.48
ROA (%)	-49.85	-55.28	-51.21	-51.80	-45.48	-54.28
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	-7,932.69	319,631.03
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	35.81	30.15	36.15	24.62	23.82	-58.83
Net Profit Growth (%)	36.48	29.71	36.54	25.02	26.57	-65.18
EPS Growth (%)	38.02	0.31	0.44	0.25	0.27	-0.52
Book Value Growth (%)	-88.50	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-0.82	-0.03	-0.03	-0.03	-0.09
Price / Book Value	3.54	2.00	0.03	0.02	0.02	0.05
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.87	-0.34	0.80	0.87	1.21	1.69
Close Price ($)	4.88	11.80	11.34	20.20	27.60	127.00
High Price ($)	20.00	20.20	35.80	38.40	131.00	617.40
Low Price ($)	3.30	5.12	9.02	11.50	20.80	123.60
Market Cap ($ Cr)	16.09	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	1.28	0.42	0.24	0.13	--
Short term debt to equity ratio	--	0.19	0.06	0.03	0.02	--
Current Ratio	1.22	2.07	4.07	7.22	10.74	11.02
Quick Ratio	1.22	--	--	--	--	--
Interest Coverage	--	--	--	--	-59.67	-518.16

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	465.34	120.92	263.21	670.78	1,741.39
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.